Integron Teams Up with Leading Pharmaceutical and Life Sciences Companies for IoT-Enabled Clinical Trials

  • Nov 8, 2017

The healthcare and life sciences industry continues to accelerate the adoption of mobile devices and IoT technology to simplify the patient experience, improve quality of care, and create a positive impact on patient outcomes. Within the clinical trial process, connected healthcare devices and wearable technology make the capture of patient data more efficient and cost-effective, improving the patient experience, resulting in reduced time to bring new research treatments to market.

At Integron, we are working with several leading healthcare and pharmaceutical companies to streamline the process of sourcing, provisioning, validating, securing, and connecting mobile devices that are being used for patient data collection within clinical trials across the globe. Our managed services include an implementation of Mobile Device Management (MDM), specifically tailored to the unique patient privacy and security requirements for the healthcare industry. Wrapped around these services is our Project Management and Consulting, which provide oversight and guidance for our enterprise customers looking to navigate the complexities of the IoT and connected clinical trials. For our customers, the results include lower risk, reduced costs, and improved efficiency in the operation and execution of clinical trials.

To support this effort, we've grown our partner ecosystem to include several leading companies throughout the clinical trial value chain. Earlier this year, we announced a partnership with Stefanini, a global IT outsourcing firm, Clinical Ink, an ePRO and patient engagement software provider, and have also demonstrated success with supporting connected clinical trials with mProve and Samsung Healthcare.

With over 30 clinical trials being supported by Integron across the globe, our managed connectivity and device provisioning services are being leveraged to provide a range of benefits for our customers:

  • More accurate and continuous monitoring that will lead to better data - Use of mobile devices, wearables, and IoT technology can reduce errors associated with human data collection and provide medical-grade biometrics
  • Improved Patient recruitment and retention - Remote patient monitoring and use of ePRO/eDiary software, delivered through mobile devices, improves patient experience
  • Enhanced patient experience - IoT technology and smart devices will provide patients with constant insight into their health, making them feel more at ease when entering into early phase clinical trials

Click here to read the latest case study on how Integron is helping to support connected clinical trials.